EPH85 Real-World Temporal and Indication-Specific Variation in Drivers of GLP-1 RA Discontinuation
B Cartwright(NuVasive (United States)), N. Stucky(Bellevue College), Duy Ngoc(NuVasive (United States)), Patricia J. Rodriguez(Bellevue College)
Cited by 0
Related Papers
Semaglutide vs Tirzepatide for Weight Loss in Adults With Overweight or Obesity
|JAMA Internal Medicine|2024|268
Discontinuation and Reinitiation of Dual-Labeled GLP-1 Receptor Agonists Among US Adults With Overweight or Obesity
|JAMA Network Open|2025|257
Perioperative Opioid Use and Chronic Post-Surgical Pain after Liver Transplantation: A Single Center Observational Study
|Journal of Cardiothoracic and Vascular Anesthesia|2019|25
Early MMR Vaccine Adoption During the 2025 Texas Measles Outbreak
|JAMA Network Open|2025|2
Don't Forget the Clitoris: Two Cases of Anorgasmia Due to Clitoral Dysgenesis [21I]
|Obstetrics and Gynecology|2019|0